Amgen appealed a 2009 class certification order that was upheld by the Ninth Circuit in 2011. Read more
Amgen Inc. has agreed to a $71 million settlement with 48 state attorneys general who accused the drugmaker of marketing its anemia drug Aranesp and plaque psoriasis drug Enbrel, both biolog... Read more
Thirty-six states have reached an $11 million settlement with the drug manufacturer Amgen, Inc. The agreement settles claims that the company inflated pricing data for six of its prescriptio... Read more
The U.S. Department of Justice has reached a settlement with Amgen over alleged kickback payments tied to its anemia drug. It was reported that the biotech drug maker will pay $24.9 million... Read more
On November 5, 2012, the United States Supreme Court heard oral arguments in the case of Amgen, Inc. v. Connecticut Retirement Plans & Trust Funds. Amgen, Inc. is a large pharmaceutical... Read more
The U.S. Supreme Court is considering appeals by Comcast Corp. and Amgen Inc. that could help determine what kind of evidence must be presented before companies may be the subject of class-a... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.